Indian Generics Look To Benefit From Obama Administration
This article was originally published in PharmAsia News
Executive Summary
Indian pharmaceutical makers expect to benefit from the change in administrations in the United States, with a new emphasis on support for generic drugs. India pharma insiders believe the Barack Obama administration will reform the health care system to make drugs more affordable and accessible, according to one analyst. That emphasis is seen as increasing generics use. India has more than 100 generics plants already approved by the U.S. FDA, he said, but noted the financial crisis would continue pressure to keep expenses down. (Click here for more